This is a Phase 3, randomized, observer-blinded study to evaluate the efficacy, safety, tolerability, and immunogenicity of qIRV encoding HA of 4 seasonally recommended strains (2 A strains and 2 B strains) in healthy individuals ≥18 years of age
| Research Studies » STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF |
|
|
|
|
| STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF |
|
This is a Phase 3, randomized, observer-blinded study to evaluate the efficacy, safety, tolerability, and immunogenicity of qIRV encoding HA of 4 seasonally recommended strains (2 A strains and 2 B strains) in healthy individuals ≥18 years of age |
